MPWT
CRBP icon

MassMutual Private Wealth & Trust’s Corbus Pharmaceuticals CRBP Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-148
Closed -$786 – 2378
2025
Q1 		$786 Buy
+148
New +$1.31K ﹤0.01% 2176
2023
Q1 		– Sell
-17
Closed – – 1820
2022
Q4 		$0 Hold
17
– – ﹤0.01% 1682
2022
Q3 		$0 Buy
+17
New +$120 ﹤0.01% 1647

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

MassMutual Private Wealth & Trust's CRBP Position: Q2 2025 in Review

MassMutual Private Wealth & Trust sold out of Corbus Pharmaceuticals (CRBP) in Q2 2025, closing a stake of 148 shares — an estimated $786 sold.

MassMutual Private Wealth & Trust first reported a position in CRBP in Q3 2022 and held it in 3 quarters. The position peaked at $786 in Q1 2025. 80 funds tracked by Wall St. Rank hold CRBP as of Q2 2025.

  • MassMutual Private Wealth & Trust reported no remaining Corbus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 148 Corbus Pharmaceuticals shares in Q2 2025, an estimated $786.
  • MassMutual Private Wealth & Trust first reported a position in Corbus Pharmaceuticals in Q3 2022 and held it in 3 quarters.
  • MassMutual Private Wealth & Trust's Corbus Pharmaceuticals position peaked at $786 in Q1 2025.
  • 80 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2025, filed 9 Jul 2025.